Wikidata

(Q39700576)

English

Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies

scientific article

In more languages

Statements

title
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20501616
retrieved
14 September 2017
author name string
Luigi Scotto
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20501616
retrieved
14 September 2017
Venkatraman E Seshan
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20501616
retrieved
14 September 2017
Jasmine M Zain
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20501616
retrieved
14 September 2017
publication date
25 May 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20501616
retrieved
14 September 2017
page(s)
3648-3658
1 reference
stated in
Europe PubMed Central
PubMed ID
20501616
retrieved
14 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39700576&oldid=2088978813"